Acetylleucine Mylan 500mg is an over-the-counter medication for the symptomatic treatment of vertigo and orthostatic hypotension.
Conium maculatum Boiron Homeopathic granules or doses
Vinca minor 5C 9C Tube pellets Homeopathy Boiron
CHENOPODIUM anthelminticum 5C 7C 9C homeopathic pellets Boiron
For warnings, precautions for use and contraindications, please consult the package insert for Acetylleucine Mylan 500mg, generic Tanganil.
Acetylleucine Mylan 500mg 30 tablets is an over-the-counter medication indicated for the symptomatic treatment of vertiginous crisis(positional vertigo) and hypotension.
Acetylleucine Mylan 500mg is an over-the-counter medication specially designed for the symptomatic treatment of vertiginous crisis, also known as vertigo. Thanks to its acetylleucine-based formulation, this medicine works quickly to relieve the sensations of vertigo, imbalance and discomfort associated with this condition. Restore your balance and well-being with Acetylleucine Mylan.
In addition to its effectiveness against dizziness, Acetylleucine Mylan is also recommended for the treatment of orthostatic hypotension, which manifests itself as a drop in blood pressure when standing. By regulating blood circulation and improving cerebral perfusion, this medication helps prevent the dizziness and fainting associated with this condition. Take control of your health with Acetylleucine Mylan.
Acetylleucine Mylan is available in easy-to-swallow tablets and is well tolerated by most people. Simply follow your healthcare professional's instructions for optimal results. Thanks to its effective formulation and lack of major side effects, Acetylleucine Mylan is a safe and convenient choice for the relief of vertigo and orthostatic hypotension.
For adults
Frequency of administration
On average, 3 to 4 tablets in two doses, morning and evening.
Duration of treatment
Duration of treatment varies according to clinical course; at the start of treatment or in the event of failure, dosage may be increased.
IN ALL CASES, ADHERE STRICTLY TO YOUR DOCTOR'S PRESCRIPTION.
Method of administration
Take by mouth.
Give your opinion on the advice for use and dosage of Acetylleucine Mylan 500mg 30 tablets with our partner Verified opinions after your purchase.
Acetylleucine Mylan 500mg is an antivertigo medication. It is recommended for the symptomatic treatment of vertiginous attacks.
To complement this allopathic treatment, we offer you an alternative with these homeopathic remedies recommended for vertigo:
Box of 30 tablets, available without prescription.
Fixed price.
Generic Tanganil-Gé
Caution: Acetylleucine Mylan 500mg is not a product like others. Read the package insert carefully before ordering. Keep Acetylleucine Mylan 500mg Gé out of the reach of children. If symptoms persist, ask your doctor or pharmacist for advice. Beware of incompatibilities with your current products.
The effects of Acetylleucine Mylan may vary from person to person, but you may generally begin to feel relief from dizziness within a few hours of taking the medication.
The dosage of Acetylleucine Mylan may vary depending on the severity of your symptoms and your healthcare professional's recommendations. It is generally recommended to take 1 to 2 tablets a day, to be swallowed with a glass of water.
Acetylleucine Mylan is generally well tolerated, but as with any medication, there may be side effects in some people, such as mild gastrointestinal upset. If you experience any side effects, stop taking the medication and consult your health care professional.
If you are taking other medications, it is recommended that you consult a healthcare professional before taking Acetylleucine Mylan to avoid potential interactions.
Pregnant or breastfeeding women should consult a healthcare professional before taking Acetylleucine Mylan to determine if it is suitable for their situation.
Pharmacovigilance Report an adverse drug reaction(s)
ANSM - Updated on : 23/12/2022
ACETYLLEUCINE VIATRIS 500 mg, tablet
Acetylleucine
Always take this medicine exactly as it is prescribed by your doctor, pharmacist or nurse.
- Keep this leaflet as you may need to read it again.
- Ask your pharmacist for advice and information.
- If you experience any side effects, please tell your doctor, pharmacist or nurse. This also applies to any side effects not mentioned in this leaflet. See section 4.
- You should contact your doctor if you do not feel any improvement or if you feel less well after 3 days.
What does this leaflet contain?
1. What is ACETYLLEUCINE VIATRIS 500 mg, tablet and what is it used for?
2. What do I need to know before taking ACETYLLEUCINE VIATRIS 500 mg, tablet?
3. How do I take ACETYLLEUCINE VIATRIS 500 mg, tablet?
4. What are the possible side effects?
5. How to store ACETYLLEUCINE VIATRIS 500 mg, tablet?
6. Package contents and other information.
1. WHAT IS ACETYLLEUCINE VIATRIS 500 mg, tablet AND WHAT IS IT USED FOR?
Pharmacotherapeutic class: Antivertiginous, ATC code: N07CA04.
ACETYLLEUCINE VIATRIS 500 mg, tablet contains the active substance acetylleucine.
This medicine is indicated in adults for the symptomatic treatment of vertiginous attacks.
2. WHAT DO I HAVE TO KNOW BEFORE TAKING ACETYLLEUCINE VIATRIS 500 mg, Tablet?
Never take ACETYLLEUCINE VIATRIS 500 mg, tablet:
IF IN DOUBT, ASK YOUR DOCTOR OR PHARMACIST FOR ADVICE.
Warnings and precautions
Caution with ACETYLLEUCINE VIATRIS 500 mg, tablet
If you experience allergic reactions (which may be severe, e.g. allergic shock, laryngeal edema), stop taking ACETYLLEUCINE VIATRIS and consult your doctor immediately (see also section 4).
Ask your doctor, pharmacist or nurse before taking ACETYLLEUCINE VIATRIS 500 mg, tablet.
Children and adolescents
Not applicable.
Other medicinal products and ACETYLLEUCINE VIATRIS 500 mg, tablet
ACETYLLEUCINE VIATRIS 500 mg, tablet with food, drink and alcohol
Not applicable.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to become pregnant, ask your doctor or pharmacist for advice before taking this medicine. It is not recommended to use this medicine during pregnancy.
This medicine should not be used during breast-feeding. If you discover that you are pregnant during treatment, consult your doctor, who is the only person who can decide whether or not to continue treatment.
Driving and use of machinery
Not applicable.
ACETYLLEUCINE VIATRIS 500 mg, tablet contains
Not applicable.
3. HOW DO I TAKE ACETYLLEUCINE VIATRIS 500 mg, tablet?
Always take this medicine exactly as instructed in this leaflet or as directed by your doctor or pharmacist. Check with your doctor or pharmacist if in doubt.
For adults
The recommended dose is 1.5 g to 2 g per day, i.e. 3 to 4 tablets taken twice, morning and evening.
Duration of treatment
The duration of treatment varies according to the clinical course (from 10 days to 5 or 6 weeks); at the start of treatment or in the event of failure, the dosage may be increased to 3 g or even 4 g per day, i.e. 6 to 8 tablets per day.
Method of administration
Take by mouth.
Take with a full glass of water.
If you have taken more ACETYLLEUCINE VIATRIS 500 mg, tablet than you should have
Consult your doctor or pharmacist immediately. Symptomatic treatment should be given if necessary.
If you forget to take ACETYLLEUCINE VIATRIS 500 mg, tablet
Do not take a double dose to make up for the one you have forgotten to take.
If you stop taking ACETYLLEUCINE VIATRIS 500 mg, tablet
Not applicable.
If you have any further questions about the use of this medicine, please ask your doctor or pharmacist.
4. WHAT ARE THE POSSIBLE SIDE EFFECTS?
Contact your doctor immediately if you develop any of the following symptoms, as you may require emergency medical treatment.
Allergic reactions, anaphylactoid shock (sudden severe allergic reaction with breathing difficulties, swelling, dizziness, rapid heartbeat, sweating and loss of consciousness) and laryngeal edema (swelling) have been observed at undetermined frequencies.
Other adverse reactions may occur
- Uncommon: may affect up to 1-10,000 patients
Skin reactions (rash, redness, urticaria and itching) o
- Undetermined frequency: cannot be estimated on the basis of available data
Gastrointestinal disorders (abdominal pain).
If you notice any side effects not listed in this leaflet, or if any side effects become serious, please tell your doctor or pharmacist.
Reporting side effects
If you experience any side effects, please tell your doctor, pharmacist or nurse. This also applies to any side effects not mentioned in this leaflet. You can also report adverse reactions directly via the national reporting system: Agence nationale de sécurité du médicament et des produits de santé (ANSM) and the network of Centres Régionaux de Pharmacovigilance - Website: www.signalement-sante.gouv.fr
By reporting adverse reactions, you are helping to provide more information on drug safety.
5. HOW TO CONSERVE ACETYLLEUCINE VIATRIS 500 mg, tablet?
Keep out of sight and reach of children.
Do not use this medicine after the expiration date indicated on the box. The expiration date refers to the last day of that month.
Do not dispose of any medicine down the drain or in the household waste. Ask your pharmacist to identify any medicines you no longer use. These measures will help protect the environment.
6. CONTENTS AND OTHER INFORMATION
What ACETYLLEUCINE VIATRIS 500 mg tablet contains
Acetylleucine ........................................................................................................... 500.00 mg
For one tablet.
- The other ingredients are :
Pregelatinized corn starch, heavy calcium carbonate, magnesium stearate.
What ACETYLLEUCINE VIATRIS 500 mg, tablet is and what it contains
White, biconvex, elongated tablet.
Boxes of 30, 60 or 90 tablets.
Not all presentations may be marketed.
Marketing authorization holder
1 RUE DE TURIN
69007 LYON
Marketing authorization holder
VIATRIS SANTE
1 RUE DE TURIN
69007 LYON
Z.I DE KRAFFT
67150 ERSTEIN
OR
VIATRIS SANTE
1 RUE DE TURIN
69007 LYON
OR
VIATRIS SANTE
360 AVENUE HENRI SCHNEIDER
69330 MEYZIEU
Drug names in member states of the European Economic Area
The last date on which this leaflet was revised was :
[to be completed subsequently by the holder]
{month YYYY}.
Detailed information on this drug is available on the ANSM (France) website.
